AIBT
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $0 | -$36,258 |
| 2025 Q4 | -0.00 | $0 | -$86,604 |
| 2025 Q3 | -0.00 | $0 | -$178,718 |
| 2025 Q2 | -0.00 | $0 | -$164,558 |
| 2025 Q1 | -0.04 | $2,183 | -$28,360 |
| 2024 Q4 | -0.05 | $0 | -$17,261 |
| 2024 Q3 | -0.03 | $0 | -$77,547 |
| 2024 Q2 | -0.03 | $0 | -$90,520 |